No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
926 |
4. Check minimum number of eventsNone |
926 |
5. Include endpointsNone |
926 |
6. Filter based on genotype QC (FinnGen only) |
926 |
Control definitions (FinnGen only)
- Control exclude
- G6_POLYNEU
Extra metadata
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Small fibre neuropathy
based on the number of shared cases.
Similar with more cases:
- Polyneuropathies and other disorders of the peripheral nervous system
- Neurological diseases
- Neurological diseases, wide definition
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 4420 | 1835 | 2568 |
| Only index persons | 4164 | 1744 | 2420 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.06 | 0.05 | 0.07 |
| Only index persons | 0.08 | 0.06 | 0.09 |
| Median age at first event (years) | |||
| Whole population | 63.93 | 64.22 | 63.77 |
| Only index persons | 63.81 | 64.02 | 63.66 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 926 | 406 | 520 |
| Unadjusted period prevalence (%) | 0.19 | 0.14 | 0.23 |
| Median age at first event (years) | 64.11 | 62.03 | 65.73 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 815
- Matched controls
- 8151
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G62.8
ICD-10 Finland
Other specified polyneuropathies
4503599627370496.0
323.0
761
*
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
247.2
323.0
368
27
N03AX12
ATC
gabapentin; oral
7.9
125.8
343
686
N03AX16
ATC
pregabalin; oral
5.5
100.4
396
1203
N06AX21
ATC
duloxetine; oral
5.5
57.7
192
434
G60.8
ICD-10 Finland
Other hereditary and idiopathic neuropathies
+∞
55.9
53
*
R20.2
ICD-10 Finland
Paraesthesia of skin
7.5
52.3
131
202
TAB00
NOMESCO Finland
Lumbar puncture
8.4
47.3
109
147
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
4.4
46.0
187
512
TAW99
NOMESCO Finland
Other minor neurosurgical procedure
36.2
39.9
51
15
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
5.7
38.5
118
235
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.7
35.9
321
1559
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
4.5
34.5
134
344
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.5
33.6
454
2744
AA1AD
NOMESCO Finland
CT of head and brain
2.7
32.7
284
1339
G60.0
ICD-10 Finland
Hereditary motor and sensory neuropathy
+∞
31.5
30
*
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
3.9
31.0
139
406
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
5.9
30.6
90
169
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.2
30.1
180
660
L28
ICPC
Limited function/disability (L)
3.0
28.6
190
747
N06AA09
ATC
amitriptyline; systemic
3.7
28.3
135
414
G61.8
ICD-10 Finland
Other inflammatory polyneuropathies
+∞
27.2
26
*
N29
ICPC
Neurological sympt/complt other
10.6
26.1
51
51
G63.2*E11.4
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy
34.3
25.7
33
10
N04BC05
ATC
pramipexole; oral
4.0
25.5
109
303
N03AE01
ATC
clonazepam; systemic
4.6
24.7
89
210
M48.0
ICD-10 Finland
Spinal stenosis
3.1
24.6
154
576
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.8
24.5
187
795
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.3
24.0
311
1747
N02AX02
ATC
tramadol; systemic, rectal
2.1
23.8
404
2559
A02BC02
ATC
pantoprazole; systemic
2.2
23.8
568
4171
R52.2
ICD-10 Finland
Other chronic pain
6.3
22.8
62
105
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
9.7
22.6
46
50
N06AX16
ATC
venlafaxine; oral
3.0
22.1
144
549
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
3.7
22.0
101
298
N03AX09
ATC
lamotrigine; oral
5.7
21.8
64
120
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.7
21.8
100
295
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
3.4
21.6
112
364
N28
ICPC
Limited function/disability (N)
10.5
21.6
42
42
ZX120
NOMESCO Finland
Intravenous
3.3
21.5
119
405
Z01.8
ICD-10 Finland
Other specified special examinations
2.4
21.5
216
1058
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.6
21.3
181
811
M79.6
ICD-10 Finland
Pain in limb
2.1
21.1
328
1969
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.2
21.1
278
1552
G61.0
ICD-10 Finland
Guillain-Barré syndrome
+∞
20.9
20
*
N99
ICPC
Neurological disease other
12.9
20.5
36
29
C03CA01
ATC
furosemide; systemic
2.2
20.4
274
1539
N02BE01
ATC
paracetamol; systemic, rectal
2.6
20.3
719
6056
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
9.4
20.3
42
47
A28
ICPC
Limited function/disability NOS
2.6
19.9
166
735
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
3.6
19.8
93
279
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.6
19.5
92
277
G64
ICD-10 Finland
Other disorders of peripheral nervous system
+∞
18.8
18
*
N02AA05
ATC
oxycodone; systemic
2.5
18.5
163
741
TPH04
NOMESCO Finland
Cathetrisation of vein
2.2
18.3
214
1117
H02AB06
ATC
prednisolone; systemic
1.9
18.3
406
2757
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
4.7
18.0
63
144
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.9
18.0
122
474
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
4.0
17.9
74
199
G61.9
ICD-10 Finland
Inflammatory polyneuropathy, unspecified
97.2
17.6
19
*
Z50.1
ICD-10 Finland
Other physical therapy
4.0
17.2
71
191
L17
ICPC
Foot/toe symptom/complaint
2.1
17.2
234
1305
N18
ICPC
Paralysis/weakness
8.7
16.9
36
43
XA402
NOMESCO Finland
ENMG
6.6
16.8
43
68
G72.9
ICD-10 Finland
Myopathy, unspecified
13.8
16.6
28
21
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.8
16.4
110
424
R50.9
ICD-10 Finland
Fever, unspecified
2.5
16.4
143
644
UJF32
NOMESCO Finland
Coloscopy
2.0
16.0
249
1457
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.6
15.7
122
514
R53
ICD-10 Finland
Malaise and fatigue
2.2
15.6
187
977
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.0
15.6
261
1567
M25.5
ICD-10 Finland
Pain in joint
2.0
15.5
239
1392
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
8.2
15.4
34
43
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.5
15.4
134
600
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
2.3
15.1
151
726
TK800
NOMESCO Finland
Hemodialysis
6.0
15.0
41
71
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.8
15.0
103
404
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.7
14.9
105
417
R4110
NOMESCO Finland
Physiotherapy
2.0
14.9
253
1524
A01
ICPC
Pain general/multiple sites
3.1
14.8
85
296
D47.2
ICD-10 Finland
Monoclonal gammopathy of undetermined significance (MGUS)
10.0
14.8
29
30
E11.4
ICD-10 Finland
Type 2 diabetes mellitus, with neurological complications
5.3
14.8
45
89
R42
ICD-10 Finland
Dizziness and giddiness
2.1
14.7
198
1088
H04.10
ICD-10 Finland
Dry eye syndrome
2.8
14.7
103
406
A41.9
ICD-10 Finland
Sepsis, unspecified
4.7
14.7
50
112
N06AX11
ATC
mirtazapine; oral
1.9
14.6
269
1668
G63.2*E10.4
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic polyneuropathy
81.6
14.6
16
*
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
2.5
14.6
126
559
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.0
14.6
219
1254
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
3.4
14.5
72
226
R35
ICD-10 Finland
Polyuria
3.1
14.3
81
279
N05BA04
ATC
oxazepam; oral
2.0
14.3
214
1225
SPAT1215
SPAT
Assessment of need for medical rehabilitation
4.3
14.3
53
129
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.9
14.2
290
1859
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.8
14.2
338
2285
L04AX01
ATC
azathioprine; systemic
3.9
14.2
59
160
R52.9
ICD-10 Finland
Pain, unspecified
2.9
14.0
86
314
N03AF01
ATC
carbamazepine; oral, rectal
3.5
13.9
65
195
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.8
13.5
89
337
R13
ICD-10 Finland
Dysphagia
3.0
13.2
80
288
J01DB01
ATC
cefalexin; oral
1.9
13.2
661
5614
R51.80
ICD-10 Finland
Headache
2.3
13.0
124
580
G63.2
ICD-10 Finland
Diabetic polyneuropathy
28.9
13.0
17
6
H02AB07
ATC
prednisone; oral
2.3
12.9
135
659
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
3.1
12.9
73
252
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
5.4
12.9
38
73
H02AB04
ATC
methylprednisolone; systemic
2.2
12.8
136
668
R60.0
ICD-10 Finland
Localized oedema
2.4
12.8
110
488
A02BC05
ATC
esomeprazole; systemic
1.8
12.8
340
2359
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.4
12.7
113
511
SPAT1229
SPAT
Assessment of need for aid
2.8
12.7
86
334
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.2
12.6
138
689
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.9
12.6
79
292
N05AH04
ATC
quetiapine; oral
2.2
12.6
139
696
H02AB09
ATC
hydrocortisone; systemic
5.8
12.5
35
63
G62.0
ICD-10 Finland
Drug-induced polyneuropathy
131.9
12.5
13
*
SPAT1216
SPAT
Assessment of functional ability
2.2
12.4
144
734
J01FF01
ATC
clindamycin; systemic
1.8
12.4
243
1523
A07AA02
ATC
nystatin; oral
3.0
12.4
72
254
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
4.1
12.3
48
123
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
5.0
12.3
39
81
UKC02
NOMESCO Finland
Cystoscopy
2.1
12.3
163
884
S18
ICPC
Laceration/cut
1.7
12.3
365
2609
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.1
12.2
160
861
R07.4
ICD-10 Finland
Chest pain, unspecified
1.8
12.0
243
1535
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
3.1
12.0
67
227
R4120
NOMESCO Finland
Occupational therapy
2.9
12.0
73
265
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
4.0
11.9
48
127
N02AJ06
ATC
codeine and paracetamol; systemic
1.7
11.8
300
2038
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.8
11.8
226
1400
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.0
11.8
157
851
M54.1
ICD-10 Finland
Radiculopathy
3.9
11.6
47
125
J01MA02
ATC
ciprofloxacin; systemic
1.7
11.6
329
2307
E0000UV
ATC
NA
1.7
11.6
302
2063
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
3.0
11.5
66
231
B03XA02
ATC
darbepoetin alfa; parenteral
5.7
11.4
32
58
Z49.1
ICD-10 Finland
Extracorporeal dialysis
7.4
11.3
26
36
JN3AD
NOMESCO Finland
Abdominal CT examination
2.7
11.3
80
317
J01EA01
ATC
trimethoprim; systemic
1.9
11.3
196
1174
SPAT1295
SPAT
Other function in accordance with physical therapy nomenclature
3.1
11.1
60
201
L04AA06
ATC
mycophenolic acid; systemic
5.5
11.1
32
60
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.1
11.0
133
691
A03FA01
ATC
metoclopramide; systemic, rectal
1.9
11.0
181
1059
127
Kela drug reimbursment
Transplant complication
6.4
11.0
28
45
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.5
10.9
85
358
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.7
10.9
326
2309
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.7
10.8
376
2778
N06AB04
ATC
citalopram; systemic
1.9
10.8
173
1005
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
5.2
10.7
32
63
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
3.1
10.7
57
190
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.2
10.6
108
520
SPAT1301
SPAT
No procedures
1.7
10.6
256
1703
NJ3CG
NOMESCO Finland
Extensive MRI examination of extremities with median high magnet
14.4
10.5
17
12
M54.5
ICD-10 Finland
Low back pain
1.7
10.5
258
1724
A02BA02
ATC
ranitidine; systemic
1.9
10.5
165
950
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
2.6
10.4
76
308
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.1
10.4
132
697
A06AC01
ATC
ispaghula (psylla seeds); oral
1.8
10.4
200
1235
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
2.3
10.4
100
468
N06AB10
ATC
escitalopram; oral
2.0
10.4
149
830
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
3.1
10.3
56
189
N06
ICPC
Sensation disturbance other
13.3
10.2
17
13
L30.9
ICD-10 Finland
Dermatitis, unspecified
2.0
10.1
152
857
S97
ICPC
Chronic ulcer skin
2.9
10.1
62
224
C07AB07
ATC
bisoprolol; oral
1.6
10.1
394
2983
WX002
NOMESCO Finland
Sedation and analgesia
1.9
10.1
172
1019
R52.1
ICD-10 Finland
Chronic intractable pain
9.3
10.1
20
22
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
5.4
10.1
29
55
A04AA01
ATC
ondansetron; systemic, rectal
2.8
10.0
66
252
JN4BD
NOMESCO Finland
Extensive body CT
2.1
10.0
115
583
E10.4
ICD-10 Finland
Type 1 diabetes mellitus, With neurological complications
12.4
9.9
17
14
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.0
9.8
143
799
SPAT1231
SPAT
Assessment of adjustments needed in living environment
4.7
9.8
32
70
B81
ICPC
Anaemia vit B12/folate deficiency
3.5
9.7
44
130
R06.0
ICD-10 Finland
Dyspnoea
1.8
9.7
210
1343
G62.1
ICD-10 Finland
Alcoholic polyneuropathy
55.7
9.7
11
*
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
2.7
9.6
67
263
TK810
NOMESCO Finland
Hemofiltration
10.2
9.5
18
18
JN4AD
NOMESCO Finland
Body CT examination
2.4
9.5
79
342
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
3.2
9.5
48
154
R11
ICD-10 Finland
Nausea and vomiting
2.6
9.5
70
284
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.0
9.5
133
730
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
3.7
9.4
40
112
R27.0
ICD-10 Finland
Ataxia, unspecified
17.8
9.4
14
8
6BA02
NOMESCO Finland
NA
30.4
9.4
12
*
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
3.0
9.4
54
189
TPX10
NOMESCO Finland
Implantation of vascular injection port
4.0
9.3
36
93
ZXA05
NOMESCO Finland
Left side
1.7
9.3
213
1384
N05CF01
ATC
zopiclone; oral
1.7
9.2
264
1830
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
3.1
9.2
49
164
NA7BG
NOMESCO Finland
Spine and spinal cord MRI examination with high intensity magnet
13.9
9.2
15
11
R20.1
ICD-10 Finland
Hypoaesthesia of skin
13.9
9.2
15
11
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.6
9.2
68
277
G56.0
ICD-10 Finland
Carpal tunnel syndrome
2.1
9.2
108
555
H53.2
ICD-10 Finland
Diplopia
3.8
9.1
37
100
XKD00
NOMESCO Finland
Uroflowmetry
1.8
9.1
164
984
C08CA05
ATC
nifedipine; systemic
2.6
9.1
68
280
GD1AD
NOMESCO Finland
Thorax CT examination
3.2
9.1
47
154
WX408
NOMESCO Finland
General anesthesy, balanced
1.7
9.1
233
1561
V03AE01
ATC
polystyrene sulfonate; oral
7.2
9.1
21
30
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
10.2
9.0
17
17
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.6
9.0
266
1851
A06AD11
ATC
lactulose; oral
1.9
9.0
131
731
NXL00
NOMESCO Finland
Biopsy of muscle
18.8
8.9
13
7
H03AA01
ATC
levothyroxine sodium; systemic
1.8
8.9
171
1050
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
2.5
8.9
70
296
N94
ICPC
Peripheral neuritis/neuropathy
24.3
8.9
12
5
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
3.8
8.9
36
97
G04CA02
ATC
tamsulosin; oral
1.7
8.9
218
1443
G44.2
ICD-10 Finland
Tension-type headache
2.1
8.9
105
538
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
5.2
8.8
26
51
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.9
8.8
139
799
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
3.4
8.8
41
125
R39.1
ICD-10 Finland
Other difficulties with micturition
3.6
8.7
38
110
A11CC03
ATC
alfacalcidol; systemic
4.3
8.7
31
75
M23.9
ICD-10 Finland
Internal derangement of knee, unspecified
2.4
8.6
76
340
P01AB01
ATC
metronidazole; oral, rectal
1.6
8.6
290
2090
D64.9
ICD-10 Finland
Anaemia, unspecified
2.2
8.6
93
460
K59.0
ICD-10 Finland
Constipation
2.8
8.6
55
208
XW000
NOMESCO Finland
Bone marrow biopsy
3.0
8.6
47
161
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
2.5
8.5
67
283
J02AC01
ATC
fluconazole; systemic
1.6
8.5
271
1921
TPH07
NOMESCO Finland
Cathetrisation of artery
2.1
8.5
99
507
R25.1
ICD-10 Finland
Tremor, unspecified
4.3
8.5
30
72
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.6
8.5
242
1666
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.1
8.4
102
527
M04AA01
ATC
allopurinol; systemic
1.9
8.4
123
684
R1250
NOMESCO Finland
Evaluation of functional capability
4.1
8.4
31
77
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
4.6
8.4
28
63
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
2.2
8.4
82
388
R5599
NOMESCO Finland
Other rehabilitation service
4.1
8.3
31
78
XKD06
NOMESCO Finland
Physiologic investigation of micturition
3.4
8.3
38
114
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
4.0
8.3
32
83
ZXA00
NOMESCO Finland
Right side
1.7
8.3
226
1537
J01MA14
ATC
moxifloxacin; systemic
2.2
8.3
80
377
B03BA03
ATC
hydroxocobalamin; parenteral
2.7
8.3
56
218
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
3.6
8.3
36
104
PD4CG
NOMESCO Finland
Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet
6.6
8.2
20
31
TQW40
NOMESCO Finland
Remowal of suture of skin
2.4
8.2
68
295
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
5.5
8.2
23
43
M79.0
ICD-10 Finland
Rheumatism, unspecified
3.5
8.2
36
105
A46
ICD-10 Finland
Erysipelas
1.9
8.2
128
730
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
4.1
8.1
30
75
E86
ICD-10 Finland
Volume depletion
4.5
8.1
27
61
NJ3BG
NOMESCO Finland
MRI examination of extremities with high intensity magnet
17.4
8.1
12
7
N06AA10
ATC
nortriptyline; systemic
4.7
8.0
26
57
K59.09
ICD-10 Finland
Constipation, unspecified
2.5
8.0
59
242
P01BA02
ATC
hydroxychloroquine; oral
2.3
8.0
75
348
R01AD08
ATC
fluticasone; nasal
1.7
8.0
209
1403
B01AB05
ATC
enoxaparin; parenteral
1.6
8.0
249
1753
M79.1
ICD-10 Finland
Myalgia
2.0
7.9
99
521
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
6.7
7.9
19
29
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
2.5
7.9
60
249
G56.2
ICD-10 Finland
Lesion of ulnar nerve
3.3
7.8
38
120
L04AD01
ATC
ciclosporin; systemic
4.9
7.8
24
50
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
3.5
7.8
35
104
R06AE07
ATC
cetirizine; oral
1.6
7.8
307
2285
M14.6
ICD-10 Finland
Neuropathic arthropathy
45.4
7.7
9
*
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
2.4
7.7
65
286
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
2.0
7.7
101
542
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.8
7.7
141
849
Z04.9
ICD-10 Finland
Examination and observation for unspecified reason
3.1
7.7
40
133
A02BC01
ATC
omeprazole; systemic
1.6
7.7
220
1512
TKC20
NOMESCO Finland
Catheterisation of bladder
2.3
7.6
67
300
D07AC01
ATC
betamethasone; topical
1.6
7.6
266
1922
R26.2
ICD-10 Finland
Difficulty in walking, not elsewhere classified
6.2
7.6
19
31
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.7
7.5
49
188
Z71.8
ICD-10 Finland
Other specified counselling
1.7
7.5
176
1143
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
5.1
7.5
22
44
M01AB55
ATC
diclofenac, combinations; oral
2.4
7.4
63
276
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
6.5
7.4
18
28
G12.8
ICD-10 Finland
Other spinal muscular atrophies and related syndromes
80.8
7.4
8
*
C88.0
ICD-10 Finland
Waldenström macroglobulinaemia
80.8
7.4
8
*
G58.7
ICD-10 Finland
Mononeuritis multiplex
80.8
7.4
8
*
SHA03
NOMESCO Finland
Correction of physiology of bite - demanding therapy visit
4.0
7.4
28
72
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
5.4
7.4
21
40
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.3
7.4
69
320
G60.9
ICD-10 Finland
Hereditary and idiopathic neuropathy, unspecified
+∞
7.3
7
*
L16
ICPC
Ankle symptom/complaint
2.1
7.3
86
442
X59
ICD-10 Finland
Exposure to unspecified factor
1.8
7.3
144
888
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.2
7.3
77
377
N12
ICD-10 Finland
Tubulo-interstitial nephritis, not specified as acute or chronic
5.2
7.3
21
41
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.9
7.3
42
149
N05CD07
ATC
temazepam; oral
1.9
7.3
103
566
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
4.3
7.3
25
59
R03AC02
ATC
salbutamol; inhalant
1.5
7.3
381
3008
N06CA01
ATC
amitriptyline and psycholeptics; systemic
2.0
7.3
86
444
R33
ICD-10 Finland
Retention of urine
2.2
7.2
72
342
S01GX01
ATC
cromoglicic acid; ophthalmic
1.8
7.2
131
788
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.5
7.2
56
235
A12AA04
ATC
calcium carbonate; oral
4.9
7.2
22
46
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
2.3
7.2
67
311
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.8
7.1
140
863
M54.4
ICD-10 Finland
Lumbago with sciatica
1.8
7.1
125
742
XG410
NOMESCO Finland
Flow-volume spirometry
2.8
7.1
45
167
Z09.4
ICD-10 Finland
Follow-up examination after treatment of fracture
2.9
7.1
41
145
M05BA04
ATC
alendronic acid; oral
2.3
7.1
64
291
XF400
NOMESCO Finland
ECG with 12 standard connections
1.7
7.1
144
894
N18.8
ICD-10 Finland
Other chronic renal failure
3.5
7.1
31
91
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
10.1
7.0
13
13
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.7
7.0
166
1076
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
2.9
7.0
41
147
A09AA02
ATC
multienzymes (lipase, protease etc.)
4.0
7.0
26
66
J01CF05
ATC
flucloxacillin; systemic
3.0
7.0
38
131
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
3.5
7.0
31
92
M01AX05
ATC
glucosamine; oral
1.7
7.0
158
1015
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
2.2
6.9
70
336
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
7.6
6.9
15
20
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
2.2
6.9
72
351
SPAT1260
SPAT
Consultation of another employee
1.7
6.9
142
887
K07.60
ICD-10 Finland
Snapping jaw
3.1
6.9
36
121
Z31.5
ICD-10 Finland
Genetic counselling
3.1
6.9
36
121
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.7
6.9
145
912
WW500
NOMESCO Finland
Blood transfusion
2.8
6.9
41
150
SBA10
NOMESCO Finland
Measurement of excretion of saliva
8.4
6.8
14
17
G04BD12
ATC
mirabegron; oral
1.9
6.8
94
511
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
3.8
6.8
27
73
XPX04
NOMESCO Finland
Angioscopy
11.0
6.8
12
11
J01MA12
ATC
levofloxacin; systemic
1.7
6.8
149
948
137
Kela drug reimbursment
Uraemia requiring dialysis
6.2
6.8
17
28
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
6.2
6.8
17
28
TNX50
NOMESCO Finland
Removal of cutom molded cast and internal stretch
2.7
6.8
44
169
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.5
6.8
325
2509
M01AE03
ATC
ketoprofen; systemic, rectal
1.5
6.7
292
2202
SAA03
NOMESCO Finland
Extended examination of mouth
1.5
6.7
269
1992
R56.8
ICD-10 Finland
Other and unspecified convulsions
2.7
6.7
44
170
SPAT1254
SPAT
Administration of medicine
1.8
6.7
118
700
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
3.4
6.7
30
90
WX882
NOMESCO Finland
High dependency care
3.3
6.7
32
101
UJF30
NOMESCO Finland
Ileoscopy through colon
2.1
6.7
77
391
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.3
6.7
61
280
N18.0
ICD-10 Finland
End-stage renal disease
5.2
6.7
19
37
C03DA01
ATC
spironolactone; oral
2.0
6.7
89
480
SPAT1296
SPAT
Other function in accordance with occupational therapy nomenclature
5.6
6.6
18
33
ZZH40
NOMESCO Finland
Substitute of bone
7.9
6.6
14
18
ZZH21
NOMESCO Finland
Graft of patients own bone, small pieces
3.9
6.6
25
65
C07AA05
ATC
propranolol; systemic
1.7
6.6
135
840
JAH00
NOMESCO Finland
Laparotomy
3.4
6.6
30
91
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.7
6.6
144
912
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
2.2
6.6
63
295
SPAT1167
SPAT
Insertion of urinary catheter
3.0
6.6
36
125
WX892
NOMESCO Finland
Monitored bed care
2.1
6.6
72
358
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
2.0
6.6
79
411
N05BA01
ATC
diazepam; systemic, rectal
1.8
6.6
107
622
ABD30
NOMESCO Finland
Implantation of spinal stimulation device
10.1
6.5
12
12
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
2.1
6.5
72
360
M79.2
ICD-10 Finland
Neuralgia and neuritis, unspecified
3.7
6.5
26
71
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.9
6.5
88
477
SAA04
NOMESCO Finland
Special inverstigation of mouth
2.4
6.5
50
212
SPAT1153
SPAT
Removal of sutures
1.5
6.4
256
1892
G25.8
ICD-10 Finland
Other specified extrapyramidal and movement disorders
3.6
6.4
27
77
M03BX01
ATC
baclofen; systemic
4.7
6.4
20
43
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.9
6.4
87
472
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.5
6.4
259
1922
GBB00
NOMESCO Finland
Tracheostomy
5.0
6.4
19
39
K58.9
ICD-10 Finland
Irritable bowel syndrome without diarrhoea
3.1
6.4
32
105
SPAT1211
SPAT
Application of soft bandage
2.0
6.4
77
400
NE1AA
NOMESCO Finland
Pelvis X-ray examination
2.2
6.4
62
295
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
8.2
6.3
13
16
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
5.2
6.3
18
35
TQW11
NOMESCO Finland
Vacuum treatment of wound
4.1
6.3
23
58
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
3.8
6.3
25
68
G12.2
ICD-10 Finland
Motor neuron disease
9.3
6.3
12
13
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.5
6.3
361
2878
SPAT1225
SPAT
Implementation of podiatry rehabilitation plan
3.5
6.3
27
79
SPAT1104
SPAT
Monitoring of emergency patient
2.2
6.2
61
290
WW200
NOMESCO Finland
Immunization
3.2
6.2
31
101
WX722
NOMESCO Finland
PEEP
2.6
6.2
42
166
NGA20
NOMESCO Finland
Exploration of soft tissue knee or lower leg, open
26.9
6.2
8
*
G62
ICD-10 Finland
Other polyneuropathies
26.9
6.2
8
*
SPAT1263
SPAT
Sampling
1.5
6.2
321
2499
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
2.1
6.2
65
316
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
2.1
6.2
65
317
J01CA08
ATC
pivmecillinam; oral
1.5
6.2
237
1731
N03AG01
ATC
valproic acid; systemic, rectal
2.4
6.2
50
216
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.4
6.2
399
3252
N04BC04
ATC
ropinirole; oral
6.3
6.2
15
24
R52.0
ICD-10 Finland
Acute pain
3.5
6.2
27
80
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
1.9
6.2
91
510
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
3.0
6.2
35
122
NF1AA
NOMESCO Finland
Hip X-ray examination
2.1
6.1
71
361
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
2.4
6.1
52
229
SBB10
NOMESCO Finland
Teeth copy
2.5
6.1
44
180
SPAT1172
SPAT
Guidance concerning hydration
3.8
6.1
24
65
RJ411
NOMESCO Finland
NA
12.6
6.1
10
8
E87.6
ICD-10 Finland
Hypokalaemia
3.2
6.1
29
92
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.4
6.1
50
220
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
3.0
6.1
32
109
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
2.9
6.1
35
125
T89
ICPC
Diabetes insulin dependent
2.8
6.1
36
132
G97.0
ICD-10 Finland
Cerebrospinal fluid leak from spinal puncture
6.8
6.1
14
21
S29
ICPC
Skin symptom/complaint other
1.7
6.0
130
822
A10AE05
ATC
insulin detemir; parenteral
2.3
6.0
50
221
Z03.8
ICD-10 Finland
Observation for other suspected diseases and conditions
2.7
6.0
39
149
TNX33
NOMESCO Finland
Custom moulded cast, unspecified region
2.5
6.0
46
194
R20.8
ICD-10 Finland
Other and unspecified disturbances of skin sensation
6.1
6.0
15
25
I73.0
ICD-10 Finland
Raynaud syndrome
4.6
6.0
19
42
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
390
681
9.17
235.59
2.4
2.9
67.4
66.1
g/l
2.38
359
616
206
309
8.29
136.80
2.4
2.5
—
—
—
0
0
206
309
8.29
136.80
2.4
2.5
3.7
3.9
g/l
0.53
138
224
206
309
8.29
136.80
2.4
2.5
7.1
7.4
g/l
0.91
143
232
194
288
8.26
129.68
2.5
2.6
2.9
3.2
g/l
2.76
142
227
253
501
6.57
128.83
2.6
2.5
24.2
10.7
au/ml
—
8
15
187
289
7.85
120.25
2.4
2.6
9.3
10.6
g/l
2.99
154
245
171
270
7.54
107.35
2.5
2.6
0.6
1.5
g/l
1.95
152
235
164
265
7.31
100.54
1.5
1.5
156.7
165.5
titre
—
6
11
553
2435
4.16
99.59
3.4
2.1
172.2
227.2
u/l
0.87
528
2291
155
240
7.56
98.75
2.4
2.6
0.0
0.0
g/l
0.50
143
218
153
253
7.05
91.47
2.2
2.5
38.9
36.8
g/l
2.91
130
214
139
227
7.03
83.84
2.3
2.6
0.0
0.0
g/l
0.00
127
205
631
3290
3.88
83.21
2.6
2.0
98.7
94.3
pmol/l
1.33
362
1742
70
44
17.13
82.90
1.1
1.0
—
—
—
0
0
166
333
5.86
81.29
2.1
2.1
39.3
38.3
u/l
0.19
150
289
71
48
15.94
80.96
1.2
1.1
45.6
42.3
mg/l
0.15
62
42
135
224
6.88
80.10
2.4
2.6
0.0
0.0
g/l
0.00
127
204
69
49
15.13
76.56
1.1
1.1
315.0
243.6
mg/l
1.57
64
43
127
230
6.24
68.80
1.5
2.0
—
—
—
0
0
614
3431
3.34
66.42
7.9
5.0
34.8
35.2
g/l
0.96
578
3195
673
3981
3.53
66.00
13.5
7.0
1.2
1.2
mmol/l
0.67
592
3363
132
265
5.64
64.02
1.3
1.2
2.0
1.7
u/ml
0.06
14
17
106
175
6.71
62.80
1.4
1.4
5.6
56.1
e6/l
0.84
84
136
106
175
6.71
62.80
1.5
1.4
163.0
754.7
e6/l
0.46
90
141
65
58
11.98
62.80
1.1
1.1
—
—
—
0
0
70
70
10.74
62.66
1.1
1.1
—
—
—
0
0
205
606
4.06
61.52
3.7
2.5
10.3
10.7
g/l
0.54
189
556
71
75
10.17
61.11
1.1
1.1
—
—
—
0
0
351
1491
3.18
59.66
2.0
1.8
1181.5
1184.6
nmol/l
0.02
279
1123
52
36
15.24
58.30
1.1
1.0
1.1
1.1
u/l
0.09
31
19
620
3661
3.10
57.47
12.1
6.2
1.2
1.2
mmol/l
0.18
576
3322
702
4500
3.31
55.24
14.2
9.3
4.1
4.2
e9/l
0.08
644
3952
318
1339
3.09
54.02
6.3
3.3
0.8
0.8
mmol/l
0.79
297
1260
38
16
24.72
53.25
1.6
1.1
140.5
97.2
nmol/l
—
29
10
102
195
5.75
51.86
1.3
1.2
19.7
3.3
u/ml
—
7
8
269
1085
3.08
48.59
12.4
5.6
1.1
1.0
mmol/l
2.81
256
996
111
251
4.89
46.57
2.2
1.4
1.1
1.2
g/l
2.09
105
238
649
4210
2.81
45.46
9.7
6.6
11.4
12.0
umol/l
0.33
619
4001
528
3099
2.64
45.26
3.1
2.2
77.5
77.0
nmol/l
0.16
479
2738
794
5767
3.64
44.94
7.2
4.1
14.3
12.6
mm/h
2.07
748
5300
107
244
4.83
44.38
2.3
1.4
0.2
0.2
g/l
0.74
102
234
81
144
6.07
44.30
1.2
1.2
35.3
32.3
u/ml
—
9
10
589
3670
2.66
44.22
10.4
5.8
57.9
57.6
%
0.18
563
3443
593
3727
2.64
43.39
11.1
6.0
26.6
27.2
%
0.71
566
3473
328
1561
2.71
42.68
1.5
1.2
0.7
1.3
u/ml
2.48
73
406
380
1953
2.60
42.18
1.9
1.5
21.3
20.5
nmol/l
0.45
336
1657
522
3169
2.48
39.83
4.3
2.8
169.1
149.7
ug/l
0.88
479
2910
109
278
4.31
39.16
3.7
3.6
301.8
78.4
mg/l
0.41
97
225
197
749
3.07
38.60
6.6
3.9
1.9
2.0
mmol/l
0.05
168
601
108
278
4.27
38.31
3.8
3.6
28.5
48.0
mg/l
1.06
97
227
802
6060
3.42
38.26
14.3
7.9
80.8
79.9
u/l
0.19
776
5679
455
2641
2.42
37.72
4.3
3.6
2.3
2.3
mmol/l
0.57
397
2298
489
2949
2.39
36.92
5.7
3.2
—
—
—
0
0
84
184
4.92
36.42
1.3
1.2
2.0
2.8
u/ml
—
6
17
105
275
4.18
36.35
3.8
3.5
1.2
1.8
ratio
—
8
26
190
732
3.01
36.20
15.4
7.3
10.9
9.8
mmol/l
1.27
182
697
84
187
4.84
35.71
1.3
1.2
5.0
13.5
u/ml
0.55
14
25
44
50
9.19
35.67
1.5
1.3
5.4
6.4
u/l
0.42
39
39
268
1261
2.58
34.58
1.5
1.2
35.9
37.9
iu/ml
0.06
77
395
670
4722
2.52
34.49
9.4
5.0
6.9
6.7
mmol/l
0.76
650
4438
365
1994
2.37
33.82
2.7
2.2
2.8
3.1
mg/l
2.00
306
1701
73
152
5.13
33.53
1.3
1.2
1.2
1.8
u/ml
—
6
8
51
75
7.14
33.38
1.2
1.1
—
—
—
0
0
221
961
2.71
33.32
6.2
4.0
241.5
241.7
u/l
0.01
208
909
182
715
2.92
33.28
3.0
2.1
322.7
373.1
nmol/l
2.47
169
655
206
873
2.75
32.60
1.8
1.9
1.7
1.5
%
1.79
182
745
420
2504
2.24
30.94
4.9
2.5
56.7
56.6
u/l
0.02
386
2314
264
1296
2.45
30.62
3.8
2.0
29.8
29.7
s
0.12
254
1258
244
1163
2.49
30.11
4.4
2.5
2.2
2.3
g/l
1.33
226
1074
691
5105
2.39
29.31
7.5
4.3
206.9
2792.0
e6/l
—
7
79
257
1268
2.42
29.31
4.4
2.5
12.7
13.0
umol/l
0.34
237
1170
154
594
2.91
28.87
6.5
3.9
108.9
88.8
ng/l
1.08
135
519
41
57
7.48
28.17
3.8
2.1
688.5
724.0
e6/l
0.08
14
24
230
1102
2.45
27.82
4.7
2.5
23.0
23.0
%
0.03
198
936
174
734
2.69
27.42
9.2
7.7
1.3
1.4
mmol/l
0.20
168
703
268
1389
2.31
27.00
2.6
1.8
—
—
—
0
0
264
1383
2.27
25.76
4.1
2.8
0.9
0.9
e6/l
0.17
178
802
733
5684
2.39
25.74
5.1
3.8
14.8
14.9
pmol/l
0.54
672
5091
28
27
10.66
25.44
1.2
1.0
1957.6
1684.7
miu/ml
0.38
28
27
28
28
10.28
24.81
1.2
1.1
37.2
510.7
ng/l
—
9
7
542
3787
2.04
24.22
5.6
3.6
0.0
0.0
estimate
0.80
81
705
371
2263
2.07
24.22
5.2
3.1
0.3
0.5
e6/l
1.51
309
1719
537
3741
2.04
24.18
5.5
3.6
0.0
0.0
estimate
0.00
82
730
298
1691
2.12
23.46
2.3
1.7
1.6
1.2
mg/l
0.36
239
1305
19
11
17.61
22.96
1.0
1.0
8.9
7.2
mg/g
0.45
19
11
398
2528
2.01
22.89
4.9
3.4
32.6
33.7
u/l
0.32
380
2407
390
2463
2.01
22.77
3.6
3.0
1845.5
1298.1
ng/l
1.44
339
2121
199
970
2.34
22.70
2.4
1.8
—
—
—
0
0
108
391
2.99
22.48
2.9
2.0
1.5
1.5
g/l
0.15
86
341
199
974
2.33
22.46
2.4
1.8
—
—
—
0
0
36
56
6.65
22.32
1.0
1.2
2.4
4.4
nmol/l
—
7
11
529
3737
1.97
22.07
7.4
4.9
0.0
0.0
estimate
0.50
87
738
296
1709
2.08
22.01
3.8
2.6
5.7
5.3
e6/l
0.14
270
1511
104
379
2.96
21.37
7.3
4.4
23.5
24.3
mmol/l
1.52
93
345
170
794
2.40
21.26
3.2
2.3
0.2
0.2
g/l
0.82
160
743
656
5028
2.04
21.23
4.8
3.2
58.6
53.1
u/l
0.63
612
4679
137
579
2.60
21.21
2.2
1.7
—
—
—
0
0
99
358
2.98
20.61
2.6
1.9
0.9
2.1
ug/l
0.77
90
319
64
179
3.77
20.07
10.6
6.2
533.9
256.8
iu/ml
1.05
13
29
820
6935
2.59
19.68
6.5
4.6
2.0
2.1
mu/l
0.36
770
6266
289
1713
2.00
19.60
1.8
1.7
13502552.6
29374538.6
pmol/l
0.40
237
1406
456
3156
1.88
19.28
5.1
3.7
42.7
48.8
ng/l
0.20
356
2304
873
7654
3.46
18.98
33.6
15.2
24.6
25.6
mg/l
0.36
770
6121
122
517
2.57
18.70
2.0
1.6
—
—
—
0
0
188
970
2.18
18.36
13.4
7.7
1.1
1.2
mmol/l
0.05
149
759
23
27
8.71
18.07
1.1
1.0
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
28
42
6.84
17.93
1.2
1.2
—
—
—
0
0
28
44
6.53
17.18
3.1
2.1
17.8
13.3
%
0.64
18
23
333
2147
1.86
17.09
4.1
2.7
5630.3
6409.4
umol/l
0.10
291
1847
149
719
2.28
17.06
3.5
2.5
38.4
39.4
u/l
0.05
131
608
230
1314
2.00
16.97
4.8
3.0
2.6
2.2
e6/l
0.22
150
739
67
220
3.20
16.41
5.2
2.8
3.8
3.7
g/l
0.24
67
211
53
152
3.64
16.02
1.4
1.3
—
—
—
0
0
53
152
3.64
16.02
1.4
1.3
—
—
—
0
0
212
1207
1.98
15.66
1.4
1.2
3.5
11.9
u/ml
2.70
76
454
255
1549
1.89
15.51
5.9
3.9
151.6
308.5
ng/l
1.78
216
1264
147
733
2.20
15.47
2.6
2.5
11.3
7.3
ug/l
0.45
118
654
25
39
6.56
15.43
1.1
1.1
—
—
—
0
0
26
43
6.19
15.19
3.1
2.3
—
—
—
0
0
244
1474
1.89
15.04
3.1
3.2
2.5
2.4
mmol/l
0.59
223
1309
39
94
4.29
14.97
2.0
1.8
—
—
—
0
0
22
31
7.25
14.88
1.0
1.2
—
—
—
0
0
190
1061
1.99
14.75
27.6
26.4
1.1
1.3
inr
0.82
15
150
18
20
9.16
14.70
1.2
1.1
—
—
—
0
0
18
20
9.16
14.70
1.2
1.1
—
—
—
0
0
67
235
3.00
14.67
1.7
1.6
0.2
0.1
iu/ml
0.22
13
40
105
474
2.37
13.93
2.0
1.4
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
73
277
2.78
13.86
8.7
3.0
0.4
0.4
u/ml
0.00
48
158
167
910
2.02
13.83
4.3
2.8
10.0
8.8
umol/l
0.18
143
799
181
1015
1.97
13.81
12.6
7.6
—
—
—
0
0
116
551
2.26
13.68
5.0
4.1
1.8
1.8
mmol/l
0.03
96
417
64
228
2.94
13.64
1.6
1.6
—
—
—
0
0
35
85
4.24
13.31
2.1
1.9
—
—
—
0
0
97
435
2.37
13.05
11.5
10.6
24.0
24.5
mmol/l
0.76
88
411
294
1950
1.74
13.01
4.0
2.4
—
—
—
0
0
119
584
2.19
12.94
5.1
4.0
5.3
5.2
kpa
0.61
111
549
879
8002
2.94
12.66
36.7
17.7
139.2
139.7
mmol/l
4.78
870
7800
22
37
6.07
12.63
1.4
1.2
—
—
—
0
0
879
8021
2.89
12.23
37.1
17.8
4.0
4.0
mmol/l
2.17
866
7809
12
10
12.14
11.76
1.3
1.0
—
—
—
0
0
12
10
12.14
11.76
1.3
1.0
—
—
—
0
0
57
207
2.87
11.75
2.5
1.7
—
—
—
0
0
56
202
2.89
11.68
6.7
3.1
33.9
34.1
umol/l
0.03
49
165
31
78
4.08
11.28
1.1
1.4
—
—
—
0
0
19
31
6.24
11.23
1.1
1.1
—
—
—
0
0
50
175
2.96
11.01
1.7
1.6
—
—
—
0
0
16
22
7.38
11.01
1.3
1.2
—
—
—
0
0
16
22
7.38
11.01
1.2
1.2
—
—
—
0
0
342
2448
1.63
10.95
3.8
3.3
2746.6
219.3
mg/l
3.66
241
1590
31
80
3.97
10.91
2.4
2.5
—
—
—
0
0
28
67
4.28
10.87
1.2
1.1
—
—
—
0
0
886
8180
2.92
10.85
20.0
10.9
25.9
26.8
u/l
1.00
863
7881
13
14
9.40
10.78
1.1
2.4
—
—
—
0
0
39
119
3.38
10.78
1.4
1.1
59.3
93.0
iu/ml
0.20
11
25
44
146
3.11
10.63
1.8
1.4
104.1
102.9
u/ml
—
9
24
56
217
2.68
10.23
2.4
1.7
—
—
—
0
0
21
42
5.09
10.08
2.5
2.8
754.9
1635.8
u/ml
0.77
21
42
474
3717
1.56
10.03
6.1
4.1
—
—
—
0
0
45
157
2.96
9.98
2.1
1.6
—
—
—
0
0
44
152
2.99
9.93
2.5
1.8
—
—
—
0
0
85
405
2.21
9.91
3.1
3.5
4.3
4.5
pmol/l
0.94
75
355
60
245
2.55
9.88
2.0
1.5
—
—
—
0
0
116
625
1.98
9.77
4.7
2.8
60.8
63.8
ml/min/173m2
0.25
49
259
15
22
6.91
9.75
1.2
1.1
—
—
—
0
0
247
1670
1.65
9.72
6.2
3.9
1.0
1.0
kg/l
0.45
40
225
53
206
2.67
9.64
2.0
1.5
—
—
—
0
0
54
214
2.62
9.45
1.5
1.3
—
—
—
0
0
805
7234
1.86
9.32
7.9
6.1
41.2
40.2
mmol/mol
1.56
748
6675
832
7559
1.99
9.28
5.8
4.8
6.1
6.0
mmol/l
1.19
765
6829
27
71
3.89
9.28
1.5
1.3
—
—
—
0
0
45
164
2.83
9.25
1.5
1.2
—
—
—
0
0
29
81
3.66
9.16
1.5
1.3
—
—
—
0
0
43
155
2.86
9.02
1.4
1.2
276.2
290.6
u/ml
0.10
28
93
346
2574
1.55
8.98
3.6
3.2
6.8
7.8
mmol/l
3.70
297
2123
148
889
1.79
8.88
3.4
4.4
195.9
27.3
ug/l
0.43
124
743
17
33
5.23
8.43
2.7
1.8
—
—
—
0
0
77
377
2.14
8.40
5.4
4.6
24.9
24.9
mmol/l
0.05
71
357
38
135
2.89
8.20
2.1
1.5
—
—
—
0
0
17
34
5.07
8.16
2.8
1.8
—
—
—
0
0
343
2591
1.51
8.09
4.3
4.0
17.4
8.7
mg/mmol
2.13
234
1673
35
120
2.99
8.04
2.1
1.6
—
—
—
0
0
65
303
2.23
8.01
3.9
3.1
—
—
—
0
0
14
24
5.91
7.87
5.0
1.9
—
—
—
0
0
282
2062
1.53
7.67
6.6
3.9
0.0
0.0
estimate
0.69
81
702
18
40
4.57
7.67
1.2
1.0
—
—
—
0
0
11
15
7.41
7.56
1.1
1.1
—
—
—
0
0
45
183
2.53
7.52
1.4
1.4
12.7
8.9
u/l
0.63
32
147
34
120
2.90
7.44
1.9
1.6
—
—
—
0
0
16
33
4.92
7.43
2.8
1.8
—
—
—
0
0
64
306
2.17
7.42
2.1
1.7
—
—
—
0
0
53
234
2.34
7.42
1.5
1.2
—
—
—
0
0
53
234
2.34
7.42
1.7
1.5
295.0
285.9
ug/g
0.10
30
147
46
191
2.48
7.36
1.2
1.1
—
—
—
0
0
113
663
1.80
7.30
2.9
2.2
12.1
13.1
nmol/l
0.52
100
580
19
46
4.20
7.30
1.3
1.7
—
—
—
0
0
19
46
4.20
7.30
1.3
1.7
—
—
—
0
0
27
84
3.28
7.29
2.2
1.5
—
—
—
0
0
27
84
3.28
7.29
2.2
1.5
—
—
—
0
0
27
84
3.28
7.29
2.2
1.5
—
—
—
0
0
26
80
3.31
7.15
1.3
1.2
45.0
51.9
u/l
0.58
21
58
26
81
3.27
7.01
2.6
2.6
—
—
—
0
0
114
680
1.77
6.96
3.9
3.0
209.7
190.6
ng/l
0.17
103
619
370
2910
1.45
6.84
6.3
3.8
—
—
—
0
0
135
850
1.69
6.80
4.6
3.4
—
—
—
0
0
47
205
2.36
6.78
3.3
2.7
221.4
192.3
%
1.11
47
195
66
337
2.03
6.48
2.8
1.9
—
—
—
0
0
82
452
1.89
6.46
1.6
1.2
217.0
267.1
u/ml
0.26
75
409
18
46
3.97
6.46
1.7
1.3
—
—
—
0
0
891
8482
2.34
5.98
46.3
22.3
4.4
4.5
e12/l
12.89
874
8246
891
8484
2.33
5.95
46.6
22.4
131.0
135.9
g/l
16.09
886
8355
792
7287
1.60
5.92
27.0
14.1
77.5
79.2
ml/min/173m2
1.09
698
6035
32
125
2.62
5.84
1.3
1.3
—
—
—
0
0
17
46
3.75
5.66
2.7
1.6
—
—
—
0
0
17
46
3.75
5.66
2.7
1.6
—
—
—
0
0
17
46
3.75
5.66
2.7
1.6
—
—
—
0
0
752
6862
1.51
5.60
34.7
16.4
37.3
39.9
%
7.45
488
4749
700
6302
1.45
5.54
37.7
18.6
14.0
13.7
%
2.51
694
6177
47
225
2.15
5.49
3.9
2.9
24.7
25.0
mmol/l
0.14
42
196
47
229
2.11
5.26
1.7
1.3
—
—
—
0
0
75
430
1.81
5.25
1.4
1.2
150.9
142.8
iu/ml
0.07
25
165
20
64
3.17
5.21
1.1
1.1
—
—
—
0
0
20
64
3.17
5.21
1.1
1.1
—
—
—
0
0
31
127
2.49
5.17
2.7
2.2
6.6
2242.7
u/l
—
9
47
20
65
3.12
5.09
1.1
1.1
—
—
—
0
0
20
65
3.12
5.09
1.1
1.1
—
—
—
0
0
20
65
3.12
5.09
1.1
1.1
—
—
—
0
0
513
4414
1.36
5.08
3.0
2.7
—
—
—
0
0
16
46
3.52
4.91
2.8
1.6
—
—
—
0
0
13
32
4.11
4.91
2.2
1.7
59.8
54.1
ug/l
0.18
13
32
14
37
3.83
4.82
1.3
1.5
—
—
—
0
0
9
10
9.07
4.79
5.3
6.2
—
—
—
0
0
816
7646
1.57
4.67
5.4
4.6
4.5
4.6
mmol/l
1.66
749
7031
38
180
2.16
4.59
1.5
1.4
—
—
—
0
0
828
7792
1.59
4.56
6.0
5.1
2.6
2.7
mmol/l
1.56
756
7121
13
35
3.75
4.37
2.0
1.7
—
—
—
0
0
46
239
1.97
4.37
1.2
1.1
—
—
—
0
0
41
205
2.05
4.33
1.9
1.7
10530.8
16072.3
e6/l
0.58
36
150
46
241
1.96
4.28
1.2
1.1
—
—
—
0
0
808
7591
1.51
4.17
5.3
4.5
1.4
1.4
mmol/l
0.62
736
6929
38
189
2.05
4.08
1.4
1.3
—
—
—
0
0
785
7345
1.45
4.02
5.1
4.1
1.4
1.3
mmol/l
2.33
714
6676
20
75
2.70
4.01
1.9
2.0
—
—
—
0
0
17
59
2.92
3.91
1.6
1.5
15.3
12.7
u/l
0.51
17
53
38
193
2.01
3.87
1.9
1.6
—
—
—
0
0
37
187
2.02
3.83
2.8
2.3
142.6
130.6
g/l
2.04
26
139
7
8
8.81
3.77
1.1
1.4
—
—
—
0
0
36
182
2.02
3.73
2.3
3.9
181.2
2075.0
u/ml
0.76
31
171
25
109
2.33
3.71
1.9
1.2
2.6
4.4
u/ml
—
8
33
8
12
6.71
3.68
1.0
1.2
—
—
—
0
0
395
3375
1.30
3.66
5.1
5.1
2.0
2.6
ug/l
1.09
350
3007
25
110
2.31
3.64
1.9
1.2
5.0
6.3
u/ml
0.16
14
50
41
222
1.89
3.51
1.6
1.4
25.6
27.0
iu/l
0.11
33
190
27
125
2.19
3.51
2.3
1.7
—
—
—
0
0
22
93
2.40
3.50
1.1
1.0
2.4
1.8
u/ml
—
9
35
16
58
2.79
3.43
1.5
1.3
—
—
—
0
0
32
161
2.02
3.38
1.4
1.4
—
—
—
0
0
18
71
2.57
3.31
1.4
1.5
0.2
0.4
nmol/l
1.15
13
52
13
43
3.05
3.26
1.2
1.3
—
—
—
0
0
22
97
2.30
3.21
2.4
1.9
—
—
—
0
0
8
15
5.37
3.19
4.4
1.1
78.1
86.1
%
—
8
15
8
15
5.37
3.19
4.4
1.1
—
—
—
0
0
145
1092
1.39
3.14
1.7
1.4
—
—
—
0
0
9
20
4.53
3.12
1.8
1.4
—
—
—
0
0
33
590
0.54
3.06
2.0
1.8
—
—
—
0
0
8
16
5.03
3.05
1.0
1.3
—
—
—
0
0
23
106
2.20
3.05
1.6
1.5
—
—
—
0
0
23
106
2.20
3.05
1.6
1.5
—
—
—
0
0
23
106
2.20
3.05
1.6
1.5
—
—
—
0
0
23
107
2.18
2.98
1.6
1.5
—
—
—
0
0
23
107
2.18
2.98
1.5
1.5
—
—
—
0
0
23
107
2.18
2.98
1.6
1.5
—
—
—
0
0
8
17
4.74
2.92
1.1
1.1
—
—
—
0
0
14
52
2.72
2.89
1.1
1.2
—
—
—
0
0
22
102
2.19
2.88
1.9
1.4
2027.0
1736.1
e6/l
0.14
15
69
9
22
4.12
2.88
1.1
1.1
—
—
—
0
0
7
13
5.42
2.87
15.0
5.8
9.2
6.3
mmol/l
—
7
13
17
71
2.42
2.81
1.9
1.3
21.6
33.3
%
0.66
11
46
14
53
2.67
2.80
1.1
1.2
—
—
—
0
0
7
14
5.03
2.73
1.1
1.0
—
—
—
0
0
38
221
1.75
2.65
2.5
2.5
70.5
81.5
ug/min
0.13
22
129
13
49
2.68
2.63
1.0
1.3
—
—
—
0
0
18
80
2.27
2.62
7.4
3.6
67.8
52.2
%
2.13
13
57
5
7
7.17
2.55
1.0
1.1
—
—
—
0
0
6
11
5.48
2.54
1.7
1.3
159.5
77.3
ng/l
—
6
11
13
50
2.62
2.54
1.3
1.8
—
—
—
0
0
14
56
2.52
2.54
1.4
1.2
1.3
1.0
u/ml
—
8
29
55
362
1.55
2.41
1.2
1.2
—
—
—
0
0
6
12
5.02
2.40
1.2
1.1
—
—
—
0
0
6
12
5.02
2.40
1.3
1.2
—
—
—
0
0
5
8
6.28
2.37
1.6
5.2
—
—
—
0
0
7
17
4.14
2.36
2.1
1.6
—
—
—
0
0
16
71
2.28
2.35
1.1
1.0
—
—
—
0
0
10
35
2.88
2.31
1.3
1.1
434.6
205.8
iu/ml
—
10
35
8
23
3.50
2.27
1.0
1.2
—
—
—
0
0
14
61
2.31
2.15
1.1
1.2
—
—
—
0
0
33
197
1.70
2.14
1.6
1.9
—
—
—
0
0
19
96
2.00
2.06
1.8
1.5
71.8
59.7
%
0.64
13
65
246
2107
1.23
2.01
1.8
1.7
1.5
1.4
mmol/l
1.41
217
1739
30
178
1.71
2.01
3.3
2.7
17.7
16.2
%
1.20
21
94
88
666
1.36
1.90
6.8
3.8
1.2
1.2
mmol/l
0.18
79
583
39
252
1.57
1.90
1.7
2.0
—
—
—
0
0
49
334
1.49
1.88
2.7
3.7
22.3
4258.4
u/ml
0.80
43
286
7
23
3.06
1.80
1.3
1.1
—
—
—
0
0
21
117
1.81
1.75
1.1
1.1
—
—
—
0
0
126
1016
1.28
1.75
4.7
4.6
31.3
31.9
%
0.22
78
671
22
125
1.78
1.73
2.0
1.7
—
—
—
0
0
5
13
3.86
1.71
1.2
1.0
—
—
—
0
0
5
13
3.86
1.71
1.0
1.5
—
—
—
0
0
6
19
3.17
1.66
2.8
1.4
—
—
—
0
0
7
25
2.81
1.65
1.1
1.2
10.4
9.1
ug/l
—
7
25
7
26
2.70
1.58
1.1
1.0
—
—
—
0
0
11
50
2.21
1.57
1.4
1.4
—
—
—
0
0
11
50
2.21
1.57
1.4
1.4
—
—
—
0
0
24
146
1.66
1.52
1.3
1.1
—
—
—
0
0
14
72
1.96
1.49
2.0
2.3
625.9
633.1
ml
—
8
45
303
2722
1.17
1.42
4.2
4.4
23.9
21.1
%
1.89
141
1345
18
103
1.76
1.41
1.1
1.1
—
—
—
0
0
16
89
1.81
1.38
2.2
1.4
11176.7
35604.2
e6/l
—
9
51
9
41
2.21
1.37
2.4
1.1
—
—
—
0
0
5
17
2.95
1.36
1.2
1.4
—
—
—
0
0
14
75
1.88
1.35
1.1
1.1
96.9
97.5
%
0.03
14
70
0
37
0.00
1.34
0.0
1.2
—
—
—
0
0
17
99
1.73
1.27
1.3
1.1
1.0
1.3
u/ml
—
8
41
6
25
2.41
1.24
1.5
1.3
0.0
2.4
mmol/l
—
6
25
12
63
1.92
1.23
1.1
1.0
19.7
47.0
ng/l
—
7
37
12
63
1.92
1.23
1.1
1.0
162.6
333.0
ng/l
—
7
39
16
93
1.73
1.21
1.3
1.3
267.6
318.8
pmol/l
0.24
11
72
45
332
1.37
1.21
1.1
1.0
—
—
—
0
0
10
50
2.01
1.16
1.7
1.6
9.6
7.9
u/l
—
5
29
7
30
2.34
1.12
2.4
4.7
—
—
—
0
0
22
144
1.54
1.09
5.3
3.7
53.5
57.3
%
0.79
22
144
5
22
2.28
1.03
1.0
1.8
—
—
iu/ml
—
0
0
5
22
2.28
1.03
1.4
1.1
—
—
—
0
0
17
106
1.62
1.03
1.4
1.0
—
—
—
0
0
9
47
1.92
1.02
2.0
1.6
1.0
1.0
g/l
—
9
47
5
23
2.18
0.98
3.8
1.3
—
—
—
0
0
21
140
1.51
0.98
4.7
3.3
3.8
4.4
e9/l
0.47
21
140
10
54
1.86
0.97
2.5
1.7
—
—
—
0
0
15
94
1.61
0.91
1.7
1.7
—
—
—
0
0
11
63
1.76
0.90
1.1
1.0
850.0
600.1
ng/l
—
6
38
99
843
1.20
0.90
1.5
1.4
—
—
—
0
0
6
29
2.08
0.89
23.0
10.2
0.6
0.6
mmol/l
—
6
29
11
65
1.70
0.82
2.8
3.2
22.6
46.1
u/ml
0.81
11
65
6
32
1.88
0.82
1.2
1.4
—
—
—
0
0
34
264
1.30
0.72
1.4
1.9
3.8
3.1
mg/l
0.39
26
198
11
68
1.63
0.72
2.7
1.8
—
—
—
0
0
16
109
1.48
0.71
1.6
2.0
91.0
89.6
%
0.84
16
109
22
163
1.36
0.64
1.3
1.3
138.7
223.6
miu/ml
—
7
72
14
96
1.47
0.61
3.6
4.8
—
—
—
0
0
6
38
1.58
0.54
1.0
1.1
—
—
—
0
0
15
110
1.37
0.49
1.2
1.1
—
—
—
0
0
7
47
1.49
0.47
3.3
1.7
—
—
—
0
0
7
48
1.46
0.47
3.3
1.7
—
—
—
0
0
5
81
0.62
0.46
1.2
1.5
—
—
—
0
0
21
165
1.28
0.45
1.5
1.3
—
—
—
0
0
7
50
1.40
0.45
2.4
2.8
—
—
—
0
0
8
58
1.38
0.41
3.0
1.6
—
—
—
0
0
8
59
1.36
0.41
1.5
1.2
—
—
—
0
0
8
61
1.31
0.39
1.8
1.5
—
—
—
0
0
6
43
1.40
0.35
1.7
1.3
—
—
—
0
0
6
43
1.40
0.35
1.7
1.3
—
—
—
0
0
6
45
1.34
0.33
3.2
2.5
—
—
—
0
0
56
502
1.12
0.33
1.5
1.9
—
—
—
0
0
10
76
1.32
0.28
1.3
1.4
—
—
—
0
0
20
170
1.18
0.24
5.1
3.1
0.9
0.8
nmol/l
0.12
14
132
60
556
1.08
0.21
1.6
2.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
205
1986
1.04
0.18
3.1
3.1
0.6
0.8
ug/l
1.64
142
1332
5
67
0.74
0.17
11.0
2.2
13.7
13.1
%
—
5
67
25
228
1.10
0.13
1.9
1.7
—
—
—
0
0
13
113
1.15
0.13
2.4
2.0
32.8
32.7
pg
0.01
13
113
12
136
0.88
0.11
1.3
1.5
—
—
—
0
0
20
203
0.98
0.00
1.2
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
5
59
0.85
0.00
1.2
1.6
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
14.4
—
0
7
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint SFN and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| SFN | 2.127 [1.75, 2.58] | < 0.001 |
| Birth year | 0.998 [0.99, 1.01] | 0.556 |
During the follow-up period (1.1.1998 — 31.12.2019), 319 out of 1445 females with SFN died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| SFN | 1.787 [1.5, 2.13] | < 0.001 |
| Birth year | 0.989 [0.98, 1.0] | 0.059 |
During the follow-up period (1.1.1998 — 31.12.2019), 535 out of 2049 males with SFN died.
Mortality risk
Mortality risk for people of age
years, who have SFN.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.152% | 0.371% |
| 5 | 1.346% | 2.018% |
| 10 | 3.672% | 4.985% |
| 15 | 6.693% | 9.373% |
| 20 | 10.957% | 15.86% |
Relationships between endpoints
↥Index endpoint: SFN – Small fibre neuropathy
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data